| Financial Year |
March 31 2023 |
| Monetary Funds |
3,046,288,198.61 |
| Held-for-trading Financial Assets |
5,775.51 |
| Notes Receivable |
-- |
| Accounts Receivable |
476,113,385.61 |
| Advances to Suppliers |
560,546,170.79 |
| Other Receivables |
69,745,868.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,829,061.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,073,097.06 |
| Other Current Assets |
70,397,652.77 |
| Total Current Assets |
5,085,401,393.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
243,331,466.50 |
| Under-construction Projects |
68,665,834.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,096,427.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,341,631.67 |
| Deferred Income Tax Assets |
93,946,358.24 |
| Other Non-Current Assets |
51,596,687.67 |
| Sub-Total of Non-Current Assets |
606,850,591.95 |
| Total Assets |
5,692,251,985.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
3,690,000.00 |
| Notes Payable |
22,591,836.98 |
| Accounts Payable |
1,613,734,590.98 |
| Accounts Received In Advance |
120,748.09 |
| Employee Compensation Payable |
198,488,947.91 |
| Taxes Payable |
33,776,165.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,422,892.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,638,649.94 |
| Other Current Liabilities |
118,654,167.17 |
| Sub-Total of Current Liabilities |
3,940,518,566.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,670,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,501,023.18 |
| Deferred Income Tax Liabilities |
9,153,203.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,176,843.53 |
| Total Liabilities |
3,988,695,409.91 |
| Paid-In Capital(Or Share Stock) |
428,220,696.00 |
| Capital Surplus |
146,326,319.49 |
| Surplus Reserve |
173,639,950.15 |
| LESS:Treasury Stock |
55,712,647.08 |
| Undistributed Profits |
995,863,565.07 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,703,556,575.49 |
| Owner's Equity（Stockholder's Equity） |
1,703,556,575.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,692,251,985.40 |
